VTVTvTv Therapeutics Inc. Class A Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 23514
Ticker: VTVT
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2015-07-30
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: VTVT

Detail

Enriched 2026-08-14 20:47

Market cap: $125,170,424.12
Shares outstanding (class): 3,938,654
Shares outstanding (weighted): 3,938,654
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 26
Location: HIGH POINT, NC
Homepage: https://www.vtvtherapeutics.com
Description: vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

Market cap and share counts drift.

Funds holding this security

7 funds · 7 positions · $4.70M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$2.95M	0.00%	74,346 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$1.25M	0.00%	31,515 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$208.1K	0.02%	5,247 NS	FIGI
Small Cap Core Fund Northern Funds	—	$155.7K	0.05%	3,926 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$61.0K	0.00%	1,538 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$60.4K	0.00%	1,523 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$15.0K	0.01%	379 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERVTVT
FIGI_COMPOSITEBBG009DT9XJ0
FIGI_SHARE_CLASSBBG009DT9XK8
CIK0001641489
ISINUS9183852048
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: vTv Therapeutics is a pharmaceutical company, so it falls under healthcare and pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.